Chewy Stock: Is a Turnaround Taking Shape?

Chewy Inc, the online pet supplies retailer, appears to be staging an unexpected recovery. After a prolonged period of stock price weakness, market analysts are displaying renewed confidence in the company’s prospects. What’s driving this shift in sentiment, and can Chewy truly reignite its former growth trajectory?

Upcoming Quarterly Report to Test Recent Optimism

The company faces a critical evaluation point on December 4th, when its next quarterly earnings are scheduled for release. This report will reveal whether recent strategic initiatives are beginning to yield tangible results and if Chewy’s substantial growth investments are paying off. The question remains: can the pet supplies retailer meet the heightened expectations of increasingly optimistic market watchers, or might the recent stock recovery prove premature?

Strategic Expansion Fuels Analyst Confidence

Multiple investment firms have recently reinforced their positive outlook on Chewy. Piper Sandler maintains an “Overweight” rating with a $48 price target, suggesting substantial upside potential of 42 percent. Mizuho Securities expresses even greater optimism, setting a $50 price objective.

Analysts point to Chewy’s strategic push into the lucrative veterinary market as a primary reason for their confidence. The launch of new Chewy Vet Care clinics is expected to provide access to a market valued at $25 billion. Additionally, the company’s transition to its own advertising platform promises to generate higher advertising revenue through new formats, including video advertisements.

Should investors sell immediately? Or is it worth buying Chewy Inc?

Margin Improvement Initiatives Show Promise

A significant price increase for Chewy+ membership fees—from $49 to $79, representing a 61 percent hike—has been identified by market researchers as a potentially margin-boosting move. According to Mizuho, this adjustment could help offset profitability concerns anticipated in the second half of 2025.

The acquisition of SmartEquine further strengthens Chewy’s position within the high-margin equine health products sector. These strategic moves are designed to enhance long-term recurring revenue streams and accelerate growth rates across the business.

The coming weeks will prove decisive for Chewy as investors await concrete evidence that these strategic shifts are translating into improved financial performance.